
Cereblon modulator 1
CAS No. 1860875-51-9
Cereblon modulator 1 ( —— )
产品货号. M22617 CAS No. 1860875-51-9
Cereblon 调节剂 1 是 cereblon (CRBN) E3 连接酶调节剂。它与 CRBN 特异性结合,从而影响泛素 E3 连接酶复合物的活性。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥640 | 有现货 |
![]() ![]() |
10MG | ¥1158 | 有现货 |
![]() ![]() |
25MG | ¥2414 | 有现货 |
![]() ![]() |
50MG | ¥3969 | 有现货 |
![]() ![]() |
100MG | ¥5873 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Cereblon modulator 1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Cereblon 调节剂 1 是 cereblon (CRBN) E3 连接酶调节剂。它与 CRBN 特异性结合,从而影响泛素 E3 连接酶复合物的活性。
-
产品描述Cereblon modulator 1 is a cereblon (CRBN) E3 ligase modulator. It specifically binds to CRBN, thereby affecting the activity of the ubiquitin E3 ligase complex.Cereblon modulator 1 (compound F) that demonstrates anti-proliferative activity in non-AML hematological cancer cell lines does not inhibit cell growth in any of the 11 AML cell lines tested, including the ten cell lines that are sensitive to the growth inhibitory activity of Compound D. However, when excess Cereblon modulator 1 is added to KG-1 AML cell cultures in the presence of Compound D, the anti-proliferative activity of Compound D is reduced, presumably due to competition for binding of Compound D to CRBN. The relative impact of Cereblon modulator 1 on the anti-proliferative effect of Compound D progressively increased with increasing concentrations of Cereblon modulator 1. In the presence of 100 μΜ Cereblon modulator 1, the potency of Compound D in inhibiting cell growth reduced by approximately 60-fold, and the potency of Compound D in inducing apoptosis reduced by approximately 40-fold.
-
体外实验——
-
体内实验——
-
同义词——
-
通路PROTACs
-
靶点E3 Ligase Ligand
-
受体cereblon (CRBN) E3 ligase
-
研究领域——
-
适应症——
化学信息
-
CAS Number1860875-51-9
-
分子量461.85
-
分子式C22H18ClF2N3O4
-
纯度>98% (HPLC)
-
溶解度DMSO:240 mg/mL (519.65 mM; Need ultrasonic)
-
SMILESFC(F)(C(=O)NCc1ccc2C(=O)N(Cc2c1)C1CCC(=O)NC1=O)c1ccc(Cl)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Ellen Filvaroff, et al. Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies. WO2017120446A1.
产品手册




关联产品
-
VHL-alkyne
VHL-alkyne 是用于 PROTAC 合成的 VHL 配体。
-
E3 Ligase Ligand 2
PROTAC 的 E3 连接酶配体。
-
Thalidomide-NH-C4-NH...
Thalidomide-NH-C4-NH-Boc 是一种合成的 E3 连接酶配体-接头缀合物,其中包含基于 Thalidomide 的 cereblon 配体和 PROTAC 技术中使用的接头。